Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Experiencing urinary retention - defined as meeting at least one of the following criteria: More than 6 hours after delivery or foley catheter removal without being able to spontaneously void, Symptomatic urinary retention without being able to spontaneously void, Change in fundal height or position without being able to spontaneously void, Bladder scan showing bladder containing 400mL or more urine
18 years old or older
Must not have
Not able to void in toilet (ex: requiring use of bed pan to void)
Seizure disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 minutes
Summary
This trial is testing whether the smell of peppermint oil can help new mothers who are having trouble urinating after childbirth. Researchers hope to see if peppermint oil can help these women urinate on their own and reduce the need for catheters. Peppermint oil has been studied for its effects on nausea, vomiting, and anxiety in various populations, including pregnant women and postoperative patients.
Who is the study for?
This trial is for English-speaking women over 18 who've recently given birth at Bethesda North Mom Baby Unit and are having trouble urinating on their own. They must be able to use the toilet normally, without a bedpan. Women with peppermint allergies, asthma, active herpes lesions, or seizure disorders cannot participate.
What is being tested?
The study is testing if inhaling peppermint oil vapors helps postpartum women urinate more easily compared to inhaling mineral oil (placebo). Participants will be randomly assigned to one of these two treatments and monitored for how well they can pee without help and their satisfaction levels.
What are the potential side effects?
Peppermint oil may cause minor side effects like a cooling sensation or tingling in the area where it's applied. In rare cases, it could lead to allergic reactions. Mineral oil is generally considered safe but might cause mild irritation when inhaled.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am unable to urinate on my own and have symptoms or tests confirming this.
Select...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot use the toilet and need a bed pan.
Select...
I have a seizure disorder.
Select...
I have asthma.
Select...
I currently have active herpes sores.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Percent of patients with urinary retention resolved
Secondary study objectives
Incidence of urinary catheterization
Patient satisfaction
Time to spontaneous urination
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Peppermint OilExperimental Treatment1 Intervention
Subjects will be exposed to vapor of peppermint oil
Group II: PlaceboPlacebo Group1 Intervention
Subjects will be exposed to vapor of placebo (mineral oil)
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for urinary retention often focus on relaxing the muscles of the urinary tract to facilitate urination. For example, peppermint oil vapor is being studied for its aromatic properties, which may help relax the urinary tract muscles, thereby easing the passage of urine.
Similarly, muscle relaxants and behavioral interventions like pelvic floor exercises aim to reduce muscle tension and improve bladder function. These mechanisms are crucial for urinary retention patients as they help alleviate the discomfort and potential complications associated with the inability to empty the bladder effectively.
Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Study.Phytotherapy in the treatment of benign prostatic hyperplasia.
Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Study.Phytotherapy in the treatment of benign prostatic hyperplasia.
Find a Location
Who is running the clinical trial?
TriHealth Inc.Lead Sponsor
99 Previous Clinical Trials
53,691 Total Patients Enrolled
3 Trials studying Urinary Retention
507 Patients Enrolled for Urinary Retention
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Recently gave birthYou are allergic to peppermint.I am unable to urinate on my own and have symptoms or tests confirming this.I cannot use the toilet and need a bed pan.I am 18 years old or older.I have a seizure disorder.I have asthma.I currently have active herpes sores.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo
- Group 2: Peppermint Oil
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger